MassIVE MSV000079897

Partial Public PXD004552

MudPIT analyses of proteins associated with Piccolo and Bassoon in the presynaptic active zone

Description

We used a 3-step protocol that separates lipid-associated proteins based on their buoyant density, size and charge. All steps were conducted either on ice or at 4C. Step 1 involved a sucrose density gradient centrifugation in which ca. 100 postnatal day 4 rat brains were homogenized in buffer A (5 mM MES, pH 7.0, 0.3 M sucrose, 1 mM EDTA) containing protease inhibitor cocktail. The homogenate was centrifuged at 1,000xg for 15 min. Post-nuclear supernatant (PNS) was lysed with 10 volumes of 5 mM MES pH 7.0, 1 mM EDTA and incubated for 30 min at 4C. The lysed PNS was then centrifuged at 100,000 x g for 1 h. The pellet was resuspended in buffer A and loaded on top of a discontinuous sucrose gradient of 0.8, 1.2 and 2.0 M. The gradient was spun for 3 h at 270,000 x g. The material between 0.3 and 0.8 M sucrose was removed, diluted with 5 mM MES, pH 7.0, 1 mM EDTA to a final sucrose concentration of 0.3 M, and centrifuged at 100,000 x g for 1 h. The pellet was further resuspended in a final volume of 2 mL of PBS with protease inhibitors. In step 2, this material was applied to a gel filtration column packed with Sephacryl S-1000 Superfine matrix. The dimensions of the column were 1.5 cm wide and approximately 1.5 m tall. Material flowed through the column by gravity with elution by 1x phosphate buffered saline (PBS, pH 7.4). The flow rate was ca. 0.5 mL/min, and a BioRad Model 2110 fraction collector was used to collect 4 mL per fraction. For the final step 3 of the protocol, the four Sephacryl S-1000 fractions most highly enriched in Piccolo and Bassoon as determined by WB were pooled and applied to a column packed with Q Sepharose Fast Flow. The dimensions of this column were diameter of 2.5 cm, height of approximately 12 cm with a bed volume of 60 mL packed Q Sepharose, and the flow rate using the 2110 fraction collector was 3 mL/min and 10 mL fractions were collected. The final elution profile (all buffers in 20 mM Tris pH 7.0) was 200 mL of 150 mM NaCl to wash, then stepwise elution of 120 mL buffer with the following NaCl concentrations: 210 mM, 290 mM, 350 mM, and 1000 mM. About 40 mL of the 210 mM, 290 mM (Piccolo and Bassoon enriched), and 350 mM NaCl fractions were concentrated to about 1 mL using Amicon Centricon Plus-20 30 kDa cutoff concentrators. The final recovery was 7.5 ug in the 210 mM fraction, and 16 ug in each of the 290 mM and 350 mM fractions. The fractions were precipitated with tricholoroacetic acid, and the protein pellet was stored at -20C until further use. The second approach to identify proteins associating with Piccolo and Bassoon was an anti-Piccolo IP. The starting material was 10 mg of the fraction between 0.3 and 0.8 M sucrose after density centrifugation (step 1 above). This material was diluted to 0.3 M sucrose with 5 mM MES, pH 7.0 and centrifuged at 100,000 x g for 1 h. The pellet was resuspended and incubated for 1 h with 4 mL of solubilization buffer (5 mM MES, pH 7.0, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and protease inhibitor cocktail). Lysate was cleared by centrifugation at 100,000 x g for 1 h. One mL of supernatant was incubated with 2.5 ug anti-Piccolo rabbit antibody or 2.5 ug rabbit IgG for 4 h. A 100 uL Protein A agarose slurry (Roche) was then added and further incubated overnight. Material was transferred to a small column and washed with 20 mL solubilization buffer. Proteins were eluted twice with 200 uL 50 mM Tris, pH 6.5, 100 mM DTT, 2% SDS. This material was then extracted with 4 volumes methanol and 1-volume chloroform. This mixture was combined with water, centrifuged for 90 sec at 16,000 x g. The aqueous phase was removed and extracted again with 3 volumes of methanol. This precipitated protein was collected by centrifugation for 90 sec at 16,000 x g, methanol removed, and the speed-vacuum was used to dry the protein pellet. The 210 mM, 290 mM, and 350 mM NaCl fractions from the Mono-Q column protocol and the eluates (both IgG alone and anti-Piccolo IPs) from two separate IP experiments were subjected to Multi-dimensional Protein Identification technology. [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: presynapse ; active zone ; Trio ; Bassoon ; Piccolo

Contact

Principal Investigators:
(in alphabetical order)
Laurence Florens
Submitting User: laflorens

Publications

Terry-Lorenzo RT, Torres VI, Wagh D, Galaz J, Swanson SK, Florens L, Washburn MP, Waites CL, Gundelfinger ED, Reimer RJ, Garner CC.
Trio, a Rho Family GEF, Interacts with the Presynaptic Active Zone Proteins Piccolo and Bassoon.
PLoS One. 2016 Dec 1;11(12):e0167535. doi: 10.1371/journal.pone.0167535. eCollection 2016.

Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.